This inventor holds 1 USPTO granted patent. Top assignee: Ppd Discovery, Inc.. Active years: 2003.
Company Filing History:
Years Active: 2003
Title: Christopher T. Lowden: Innovator in Prenylation Inhibition
Introduction
Christopher T. Lowden is a notable inventor based in Raleigh, NC (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target protein prenylation. His work is essential for advancing treatments for diseases associated with this biological process.
Latest Patents
Christopher T. Lowden holds 1 patent for his invention titled "Prenylation inhibitors containing dimethylcyclobutane and methods of their synthesis and use." This patent focuses on compounds that are useful in treating diseases linked to the prenylation of proteins. It also includes methods for inhibiting protein prenylation in organisms, along with pharmaceutical compositions that comprise these compounds.
Career Highlights
Lowden is currently employed at PPD Discovery, Inc., where he continues to innovate in the pharmaceutical sector. His work is characterized by a commitment to developing effective treatments that can improve patient outcomes.
Collaborations
Throughout his career, Christopher has collaborated with esteemed colleagues, including Bradley B. Brown and Kenneth S. Rehder. These partnerships have contributed to the advancement of his research and the successful development of his inventions.
Conclusion
Christopher T. Lowden is a dedicated inventor whose work in prenylation inhibitors is paving the way for new therapeutic options. His contributions to the field of pharmaceuticals are noteworthy and continue to impact the industry positively.